CrushSCI.com
129Average days
130Median days
26Fastest days
334Longest days
842025 publications

Paper Review Records

All Paper Review Records

18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

129 days

Targeting the proteasome in Leishmania donovani : developments from preclinical to Phase I and II trials

Authors
Shyam Sundar; Sarita Singh; Priya Maurya; Vishal Kumar Singh; Rajiv KumarShow moreShow less
Affiliations
1. Banaras Hindu UniversityShow moreShow less
Source PDF DOI Publisher page
26 days

Dual antigen targeting in extramedullary multiple myeloma

Authors
Binish Javed; Shaji KumarShow moreShow less
Affiliations
1. Mayo ClinicShow moreShow less
Source PDF DOI Publisher page
65 days

Evaluating early systemic therapies in the neoadjuvant setting for the treatment of urological cancers

Authors
Panagiotis Velissarios Stamatakos; Charalampos Fragkoulis; Nikolaos Kontolatis; Konstantinos Gklinos; Christoforos Kourouniotis; Athanasios DellisShow moreShow less
Affiliations
1. General Hospital of Athens “Korgialeneio Benakeio Hellenic Red Cross”; 2. General Hospital of Athens “G. Gennimatas”; 3. National and Kapodistrian University of Athens, Hospital of Athens “Aretaieion”Show moreShow less
Source PDF DOI Publisher page
140 days

Safety, pharmacokinetics, pharmacodynamics and target-mediated drug disposition modeling of TST002, a sclerostin antibody, in men and postmenopausal women with low bone mineral density

Authors
Sufeng Zhou; Xiufen Zhu; Yuchen Sheng; Lu Wang; Feng Shao; Hua LinShow moreShow less
Affiliations
1. The First Affiliated Hospital with Nanjing Medical University; 2. Nanjing Medical University; 3. The Affiliated Hospital of Nanjing University Medical SchoolShow moreShow less
Source PDF DOI Publisher page
208 days

Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma

Authors
Carlos Torrado; Anthony P. ConleyShow moreShow less
Affiliations
1. The University of Texas MD Anderson Cancer CenterShow moreShow less
Source PDF DOI Publisher page
111 days

Peripheral cannabinoid-1 receptor antagonists in clinical development: therapeutic potential for the management of obesity and related metabolic disorders

Authors
Jonanne Talebloo; Esha Chawla; Donya Shahamati; Swas Shiv; Kishore M. GaddeShow moreShow less
Affiliations
1. University of California Irvine School of Medicine; 2. Vanderbilt University School of Medicine; 3. University of California Irvine; 4. Boston UniversityShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does EXPERT OPINION ON INVESTIGATIONAL DRUGS take to review a manuscript?

As of 2026-11-19, CrushSCI has 18 complete review records for EXPERT OPINION ON INVESTIGATIONAL DRUGS. The fastest paper went from submission to acceptance in 26 days (Dual antigen targeting in extramedullary multiple myeloma, received 2026-09-10, accepted 2026-10-06); the slowest took 334 days. The average is 129 days and the median is 130 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.